{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T04:40:20Z","timestamp":1774413620310,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP22fk0310503"],"award-info":[{"award-number":["JP22fk0310503"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.omtn.2024.102438","type":"journal-article","created":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T16:35:25Z","timestamp":1734798925000},"page":"102438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Development of novel nucleic acid therapy aimed at directly controlling liver fibrosis"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0123-8921","authenticated-orcid":false,"given":"Tomohiro","family":"Umezu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakatsu","family":"Takanashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichirou","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinari","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5360-8330","authenticated-orcid":false,"given":"Yoshiki","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2024.102438_bib1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1634\/theoncologist.2010-S4-14","article-title":"The etiology of hepatocellular carcinoma and consequences for treatment","volume":"15","author":"Sanyal","year":"2010","journal-title":"Oncol."},{"key":"10.1016\/j.omtn.2024.102438_bib2","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0168-8278(02)00429-4","article-title":"Liver fibrosis -- from bench to bedside","volume":"38","author":"Friedman","year":"2003","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.omtn.2024.102438_bib3","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/aps.2010.142","article-title":"Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets","volume":"31","author":"Severi","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.omtn.2024.102438_bib4","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s10875-005-7827-3","article-title":"Molecular aspects of regulation of collagen gene expression in fibrosis","volume":"25","author":"Bhogal","year":"2005","journal-title":"J.\u00a0Clin. Immunol."},{"key":"10.1016\/j.omtn.2024.102438_bib5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev-pathol-052016-100322","article-title":"The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer","volume":"12","author":"Affo","year":"2017","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.omtn.2024.102438_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-0030-1247135","article-title":"Mouse models of hepatocellular carcinoma","volume":"30","author":"Fausto","year":"2010","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.omtn.2024.102438_bib7","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.gastro.2013.01.002","article-title":"Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma","volume":"144","author":"Hernandez-Gea","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.omtn.2024.102438_bib8","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2024.102438_bib9","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1101\/gad.1653708","article-title":"Role of platelet-derived growth factors in physiology and medicine","volume":"22","author":"Andrae","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.omtn.2024.102438_bib10","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/BF02934089","article-title":"Expression of platelet-derived growth factor and its receptor in livers of patients with chronic liver disease","volume":"32","author":"Ikura","year":"1997","journal-title":"J.\u00a0Gastroenterol."},{"key":"10.1016\/j.omtn.2024.102438_bib11","first-page":"785","article-title":"Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis","volume":"148","author":"Pinzani","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtn.2024.102438_bib12","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/cas.12730","article-title":"Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice","volume":"106","author":"Okada","year":"2015","journal-title":"Cancer Sci."},{"key":"10.1016\/j.omtn.2024.102438_bib13","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1038\/mt.2016.127","article-title":"MiR-29a Assists in Preventing the Activation of Human Stellate Cells and Promotes Recovery From Liver Fibrosis in Mice","volume":"24","author":"Matsumoto","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2024.102438_bib14","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1111444","article-title":"Ribo-gnome: the big world of small RNAs","volume":"309","author":"Zamore","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.omtn.2024.102438_bib15","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1038\/sj.onc.1209283","article-title":"Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues","volume":"25","author":"Murakami","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.omtn.2024.102438_bib16","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1101\/gad.233585.113","article-title":"A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression","volume":"28","author":"Okada","year":"2014","journal-title":"Genes Dev."},{"key":"10.1016\/j.omtn.2024.102438_bib17","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.bbadis.2011.02.002","article-title":"MicroRNAs and the cell cycle","volume":"1812","author":"Bueno","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtn.2024.102438_bib18","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1073\/pnas.1112263109","article-title":"Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex","volume":"109","author":"Shimakami","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102438_bib19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.coph.2018.08.003","article-title":"Islet microRNAs in health and type-2 diabetes","volume":"43","author":"Wendt","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.omtn.2024.102438_bib20","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/apha.12681","article-title":"MicroRNAs in metabolism","volume":"219","author":"Vienberg","year":"2017","journal-title":"Acta Physiol."},{"key":"10.1016\/j.omtn.2024.102438_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016081","article-title":"The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families","volume":"6","author":"Murakami","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2024.102438_bib22","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nbt831","article-title":"Expression profiling reveals off-target gene regulation by RNAi","volume":"21","author":"Jackson","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2024.102438_bib23","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1073\/pnas.0308698100","article-title":"Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells","volume":"101","author":"Scacheri","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102438_bib24","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1101\/gad.1064703","article-title":"siRNAs can function as miRNAs","volume":"17","author":"Doench","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.omtn.2024.102438_bib25","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/hep.27376","article-title":"Liver sinusoidal endothelial cells in hepatic fibrosis","volume":"61","author":"DeLeve","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.omtn.2024.102438_bib26","doi-asserted-by":"crossref","first-page":"R1217","DOI":"10.1152\/ajpregu.00686.2011","article-title":"The scavenger endothelial cell: a new player in homeostasis and immunity","volume":"303","author":"Sorensen","year":"2012","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.omtn.2024.102438_bib27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/nat.2018.0736","article-title":"GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics","volume":"28","author":"Springer","year":"2018","journal-title":"Nucleic Acid Therapeut."},{"key":"10.1016\/j.omtn.2024.102438_bib28","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nbt1396","article-title":"Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone","volume":"26","author":"Sato","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2024.102438_bib29","doi-asserted-by":"crossref","first-page":"20209","DOI":"10.1074\/jbc.M113.544494","article-title":"Activated hepatic stellate cells are dependent on self-collagen, cleaved by membrane type 1 matrix metalloproteinase for their growth","volume":"289","author":"Birukawa","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2024.102438_bib30","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1002\/adhm.201500826","article-title":"In\u00a0Vivo Gene-Silencing in Fibrotic Liver by siRNA-Loaded Cationic Nanohydrogel Particles","volume":"4","author":"Kaps","year":"2015","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.omtn.2024.102438_bib31","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jhep.2015.08.026","article-title":"Hic-5 deficiency attenuates the activation of hepatic stellate cells and liver fibrosis through upregulation of Smad7 in mice","volume":"64","author":"Lei","year":"2016","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.omtn.2024.102438_bib32","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1111\/j.1478-3231.2008.01759.x","article-title":"RNA interference targeting the platelet-derived growth factor receptor beta subunit ameliorates experimental hepatic fibrosis in rats","volume":"28","author":"Chen","year":"2008","journal-title":"Liver Int."},{"key":"10.1016\/j.omtn.2024.102438_bib33","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2016.07.009","article-title":"Liver sinusoidal endothelial cells: Physiology and role in liver diseases","volume":"66","author":"Poisson","year":"2017","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.omtn.2024.102438_bib34","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1478-3231.2009.01979.x","article-title":"Hepatic sinusoidal cells in health and disease: update from the 14th International Symposium","volume":"29","author":"Smedsrod","year":"2009","journal-title":"Liver Int."},{"key":"10.1016\/j.omtn.2024.102438_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1034\/j.1600-0676.2000.020001003.x","article-title":"Morphological mechanisms for regulating blood flow through hepatic sinusoids","volume":"20","author":"McCuskey","year":"2000","journal-title":"Liver"},{"key":"10.1016\/j.omtn.2024.102438_bib36","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.molmed.2012.09.001","article-title":"Antisense oligonucleotide therapeutics for inherited neurodegenerative diseases","volume":"18","author":"Southwell","year":"2012","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.omtn.2024.102438_bib37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0167-4781(99)00138-4","article-title":"2'-carbohydrate modifications in antisense oligonucleotide therapy: importance of conformation, configuration and conjugation","volume":"1489","author":"Manoharan","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtn.2024.102438_bib38","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1089\/nat.2011.0334","article-title":"Adenosine modification may be preferred for reducing siRNA immune stimulation","volume":"22","author":"Fucini","year":"2012","journal-title":"Nucleic Acid Therapeut."},{"key":"10.1016\/j.omtn.2024.102438_bib39","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nbt.3779","article-title":"Cellular uptake and trafficking of antisense oligonucleotides","volume":"35","author":"Crooke","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2024.102438_bib43","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41586-022-05289-6","article-title":"Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis","volume":"610","author":"Filliol","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2024.102438_bib41","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/gut.2004.042127","article-title":"Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis","volume":"54","author":"Xu","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.omtn.2024.102438_bib42","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.ajpath.2014.12.017","article-title":"Cytoglobin deficiency promotes liver cancer development from hepatosteatosis through activation of the oxidative stress pathway","volume":"185","author":"Thuy","year":"2015","journal-title":"Am. J. Pathol."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124003251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124003251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T01:47:53Z","timestamp":1744508873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253124003251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2162253124003251"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102438","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of novel nucleic acid therapy aimed at directly controlling liver fibrosis","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102438","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102438"}}